Biopterin in Parkinson's disease.

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1987 English Publisher:BMJJournal:Journal of Neurology, Neurosurgery & Psychiatry, volume 50, pages 85-87 (issn: 0022-3050,

Copyright policy )

Authors: A P, Moore; P O, Behan; W, Jacobson; W L, Armarego;

doi: 10.1136/jnnp.50.1.85

pmid: 3546599

pmc: PMC1033255

Biopterin in Parkinson's disease.

- Summary
- Subjects
- Metrics

Abstract

Tetrahydrobiopterin is an essential co-factor in the natural synthesis of dopamine. Oral tetrahydrobiopterin was given in small doses to four patients with early Parkinson's disease but had no discernible effect.

Related Organizations

Australian National University
Australia
University of Cambridge
United Kingdom
Addenbrooke's Hospital
United Kingdom
Cambridge University Hospitals NHS Foundation Trust
United Kingdom

Keywords

Adult, Male, Clinical Trials as Topic, Parkinson Disease, Middle Aged, Biopterins, Random Allocation, Double-Blind Method, Humans, Female

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	10
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%